NR2C2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.62110025192908E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.00389999999562E-05 |
Normal-vs-Stage2 |
4.810600E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.056280E-02 |
Stage1-vs-Stage2 |
7.649400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.363400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.050400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.4343999987787E-08 |
Normal-vs-AfricanAmerican |
1.177380E-01 |
Normal-vs-Asian |
2.328500E-02 |
Caucasian-vs-AfricanAmerican |
3.641600E-03 |
Caucasian-vs-Asian |
5.614200E-01 |
AfricanAmerican-vs-Asian |
4.908000E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.06060000000186E-05 |
Normal-vs-Female |
4.8661999999533E-06 |
Male-vs-Female |
7.660800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.244190E-02 |
Normal-vs-Extreme_Weight |
6.22590000000089E-05 |
Normal-vs-Obese |
2.420700E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.796800E-01 |
Normal_Weight-vs-Obese |
2.067200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.190600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.90649718234681E-11 |
Normal-vs-Age(41-60Yrs) |
2.839900E-03 |
Normal-vs-Age(61-80Yrs) |
2.62669999995246E-06 |
Normal-vs-Age(81-100Yrs) |
2.800000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.698100E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.114050E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.969800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.166800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.859600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.120800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.390400E-01 |
Normal-vs-Grade 3 |
5.987800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.698600E-01 |
Grade 2-vs-Grade 4 |
7.390400E-01 |
Grade 3-vs-Grade 4 |
5.987800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.23860000051424E-07 |
Normal-vs-N1 |
3.777700E-03 |
N0-vs-N1 |
6.778300E-02 |
|
|